How practitioners view generic drugs: An opinion study from general practitioners in Maine-et-Loire (France);Médicaments génériques, le point de vue des médecins: Enquête d'opinion réalisée auprès des médecins liberaux du Maine-et-Loire

Therapie

Volumn 60, Issue 1, 2005, Pages 67-74

  Lagarce, Laurence ^a   Lusson Brisset, Catherine ^a   Bruhat, Corinne ^a   Diquet, Bertrand ^a   Lainé Cessac, Pascale ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Generic drugs; Opinion survey; Private medical practitioners

Indexed keywords

GENERIC DRUG;

DRUG COST; DRUG SAFETY; DRUG SUBSTITUTION; FRANCE; GENERAL PRACTITIONER; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK; STATISTICAL ANALYSIS; ARTICLE; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; STATISTICS;

ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; DRUGS, GENERIC; FRANCE; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG;

EID: 16344373599     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2005009     Document Type: Article

References (13)

1. Singlas E, Demarez JP. Génériques: equivalents pensez-vous? La lettre du pharmacologue 2001; 15:4-9
2. Valles JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003; 65: 269-75
3. Bouvenot G, Villani P, Bouvenot J. Le générique dans le cadre médico-économique de la prescription de médicament. Presse Med 2002; 31: 1109-14
4. Verger P, Gourbeux JC. Villant P. et al. Disposition à prescrire en dénomination commune internationale: attitude des médecins libéraux en PACA en 2002. Presse Med 2003; 32: 1022-5
5. Duneau M. Développement des médicaments génériques en France: avancées et réticences. Med Droit 2000; 43: 17-22
6. Pollak PT. Altered metabolite concentrations with amiodarone generic substitution cannot be observed without monitoring. Can J Cardiol 2001; 17 (11): 1159-63
7. Hope KA, Havrda DE. Subtherapeutic INR values associated with a switch to generic warfarin. Ann Pharmacother 2001; 35 (2): 183-7
8. Halkin H, Shapiro J, Kurnik D, et al. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching. Clin Pharmacol Ther 2003; 74 (3): 215-21
9. Ereshefsky L, Glazer WM. Comparison of the bioequivalence of generic versus branded clozapine. J Clin Psychiatr 2001; 62 Suppl. 5: 25-7
10. Savadogo LG, Sondo B, Guissou IP, et al. Hospital staff use of generic essential drugs: the case of Yolgado Ouedraogo University Hospital Centre (Burkina Faso). Same 2002; 12 (2): 257-62
11. Chiffoleau A, Yatim D, Garrec F, et al. Warning! One buflomedil may hide another one! Therapie 2000; 55: 221-3
12. Le Louet H. Médicaments génériques: l'âge de raison? La lettre du pharmacologue 2001; 15: 3
13. Bjerrum L, Foged A. Patient information leaflet: helpful guidance or a source of confusion? Pharmacoepidemiol Drug Saf 2003; 12: 55-9